Ozerlik (gatifloxacin) coated tablets 400 mg. №10

$42.80

Purpose: Targets bacterial DNA gyrase, treats bacterial infections such as respiratory tract infections.

SKU: MED60394 Category:

Description

Ozerlik (gatifloxacin) Coated Tablets 400 mg. №10

Ingredients:

Each coated tablet contains 400 mg of gatifloxacin.

Dosage:

The usual dosage is one tablet daily, or as directed by a healthcare professional.

Indications:

Ozerlik tablets are indicated for the treatment of bacterial infections. It is commonly prescribed for respiratory tract infections, urinary tract infections, and skin infections.

Contraindications:

Do not use Ozerlik tablets if you are allergic to gatifloxacin or other fluoroquinolones. It is also contraindicated in children, pregnant women, and individuals with a history of tendon disorders.

Directions:

Take Ozerlik tablets with a full glass of water, with or without food. Do not crush or chew the tablets. Complete the full course of treatment as prescribed.

Scientific Evidence:

Gatifloxacin, the active ingredient in Ozerlik tablets, has demonstrated efficacy in various clinical studies. Research published in the Journal of Antimicrobial Chemotherapy showed that gatifloxacin exhibited potent activity against a wide range of bacteria, making it a valuable option for treating infections.

Additional Information:

It is important to inform your healthcare provider about any existing medical conditions or medications before starting Ozerlik tablets. Monitor for any signs of allergic reactions or adverse effects during treatment.

Pharmacological Effects: Gatifloxacin works by inhibiting bacterial DNA gyrase, a crucial enzyme involved in DNA replication. This action leads to the disruption of bacterial cell division and ultimately the death of the bacteria.

Clinical Trials: A randomized controlled trial published in the International Journal of Infectious Diseases compared the efficacy of gatifloxacin with other antibiotics in the treatment of community-acquired pneumonia. The study concluded that gatifloxacin was highly effective and well-tolerated, showcasing its potential in managing respiratory infections.